MA26600A1 - Traitement du dysfonctionnement sexuel feminin. - Google Patents

Traitement du dysfonctionnement sexuel feminin.

Info

Publication number
MA26600A1
MA26600A1 MA25442A MA25442A MA26600A1 MA 26600 A1 MA26600 A1 MA 26600A1 MA 25442 A MA25442 A MA 25442A MA 25442 A MA25442 A MA 25442A MA 26600 A1 MA26600 A1 MA 26600A1
Authority
MA
Morocco
Prior art keywords
treatment
sexual dysfunction
female sexual
female
dysfunction
Prior art date
Application number
MA25442A
Other languages
English (en)
French (fr)
Inventor
El-Rashidy Ragab
Ronsen Bruce
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Publication of MA26600A1 publication Critical patent/MA26600A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
MA25442A 1998-01-30 1999-01-29 Traitement du dysfonctionnement sexuel feminin. MA26600A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/016,252 US5945117A (en) 1998-01-30 1998-01-30 Treatment of female sexual dysfunction

Publications (1)

Publication Number Publication Date
MA26600A1 true MA26600A1 (fr) 2004-12-20

Family

ID=21776169

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25442A MA26600A1 (fr) 1998-01-30 1999-01-29 Traitement du dysfonctionnement sexuel feminin.

Country Status (34)

Country Link
US (2) US5945117A (no)
EP (1) EP1056419A4 (no)
JP (1) JP2002501875A (no)
KR (1) KR20010040477A (no)
CN (1) CN1250221C (no)
AR (1) AR017976A1 (no)
AU (1) AU752928B2 (no)
BG (1) BG64667B1 (no)
BR (1) BR9908038A (no)
CA (1) CA2322289A1 (no)
CO (1) CO4970819A1 (no)
CR (1) CR5959A (no)
DZ (1) DZ2714A1 (no)
GC (1) GC0000096A (no)
GT (1) GT199900013A (no)
HK (1) HK1040901B (no)
HN (1) HN1999000015A (no)
HU (1) HUP0101268A3 (no)
IL (2) IL137569A0 (no)
JO (1) JO2085B1 (no)
MA (1) MA26600A1 (no)
MX (1) MXPA00007447A (no)
NO (1) NO319821B1 (no)
NZ (1) NZ506597A (no)
PA (1) PA8467801A1 (no)
PE (1) PE20000240A1 (no)
PL (1) PL194350B1 (no)
SK (1) SK11362000A3 (no)
TN (1) TNSN99008A1 (no)
TR (1) TR200002220T2 (no)
TW (1) TW550069B (no)
UY (1) UY25374A1 (no)
WO (1) WO1999038467A1 (no)
ZA (1) ZA99686B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165122A1 (en) * 1994-04-22 2002-11-07 Heaton Jeremy P. W. Method and compositions for the treatment or amelioration of female sexual dysfunction
US6395744B1 (en) * 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
AU2003204720B2 (en) * 1998-05-29 2006-06-29 Tap Pharmaceutical Products Inc. Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
AU4254799A (en) * 1998-06-22 2000-01-10 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050245494A1 (en) * 1999-07-01 2005-11-03 40 J's Llc Methods to treat one or all of the defined etiologies of female sexual dysfunction
US20050020547A1 (en) * 1999-11-08 2005-01-27 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
BR0005797A (pt) * 2000-03-20 2001-10-16 Abbott Lab Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
EP1284735A4 (en) 2000-04-07 2006-01-11 Tap Pharmaceutical Prod Inc APOMORPHINE DERIVATIVES AND METHODS OF USE
US6762202B2 (en) 2000-05-09 2004-07-13 Nitromed, Inc. Infrared thermography and methods of use
US6737084B2 (en) 2000-06-27 2004-05-18 Qualilife Compositions and methods for enhancing or treating female sexual response
WO2002007757A2 (en) 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
KR20030077538A (ko) 2000-11-15 2003-10-01 탭 파마슈티칼 프로덕츠 인코포레이티드 항우울제-유도된 성기능 장애를 아포모르핀을 사용하여치료하는 방법
MXPA03004547A (es) * 2000-11-22 2004-03-26 Abbott Lab Agonistas receptores de d4 de dopamina selectivos para el tratamiento de disfuncion sexual.
BR0207024A (pt) * 2001-02-08 2004-02-25 Pharmacia Corp Global Patent D Medicamento com ação inicial rápida para o tratamento de disfunção sexual
US20060004190A1 (en) * 2002-03-19 2006-01-05 Michael Holick Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
GB0221711D0 (en) * 2002-09-19 2002-10-30 Ardana Bioscience Ltd Methods
CA2445212A1 (en) * 2002-10-10 2004-04-10 Queen's University At Kingston Treatment of sexual dysfunction
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
BRPI0409380A (pt) * 2003-04-14 2006-04-18 Vectura Ltd composições farmacêuticas
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
GEP20084550B (en) * 2004-04-30 2008-11-25 Warner Lambert Co Substituted morpholine compounds for the treatment of central nervous system disorders
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
JP2008533193A (ja) * 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
US7618972B2 (en) * 2005-03-21 2009-11-17 Pfizer Inc Substituted triazole derivatives as oxytocin antagonists
EP1865925B1 (en) * 2005-04-08 2014-01-01 Lingual Consegna Pty Ltd Buccal delivery system
CA2618103A1 (en) * 2005-08-10 2007-02-15 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
CA2914168C (en) * 2006-03-28 2018-05-08 Atir Holding S.A. Pyrido[1,2-a]pyrimidin-4-one derivatives and their use in the treatment of sexual disorders
US7800094B2 (en) * 2007-06-11 2010-09-21 Macronix International Co., Ltd. Resistance memory with tungsten compound and manufacturing
HUE028121T2 (en) 2009-06-12 2016-11-28 Cynapsus Therapeutics Inc Sublingual apomorphine
US20130210867A1 (en) * 2010-04-15 2013-08-15 Life Science Enhancement Corporation Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
KR102161392B1 (ko) 2010-12-16 2020-10-05 선오비온 파마슈티컬스 인코포레이티드 설하 필름
EP3581567A1 (en) 2011-04-10 2019-12-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2545905A1 (en) 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited A new therapeutical composition containing apomorphine as active ingredient
JP7211706B2 (ja) 2015-04-21 2023-01-24 サノヴィオン ファーマシュティカルズ インコーポレーテッド 口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
WO1993023035A2 (en) * 1992-05-18 1993-11-25 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
CA2188385C (en) * 1994-04-22 2000-07-11 Ragab El-Rashidy Dosage forms and method for ameliorating male erectile dysfunction
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction

Also Published As

Publication number Publication date
US6193992B1 (en) 2001-02-27
CA2322289A1 (en) 1999-08-05
UY25374A1 (es) 1999-09-27
GC0000096A (en) 2005-06-29
TR200002220T2 (tr) 2000-12-21
NO20003845L (no) 2000-09-28
JO2085B1 (en) 2000-05-21
HK1040901A1 (en) 2002-06-28
NZ506597A (en) 2003-07-25
AU752928B2 (en) 2002-10-03
HUP0101268A3 (en) 2002-12-28
TNSN99008A1 (fr) 2005-11-10
AU2564499A (en) 1999-08-16
BR9908038A (pt) 2002-01-02
CO4970819A1 (es) 2000-11-07
WO1999038467A1 (en) 1999-08-05
IL137569A (en) 2006-08-01
IL137569A0 (en) 2001-07-24
MXPA00007447A (es) 2006-01-25
ZA99686B (en) 1999-07-28
SK11362000A3 (sk) 2001-02-12
PE20000240A1 (es) 2000-03-31
EP1056419A1 (en) 2000-12-06
TW550069B (en) 2003-09-01
DZ2714A1 (fr) 2003-09-01
HN1999000015A (es) 1999-08-23
CR5959A (es) 1999-07-28
CN1313742A (zh) 2001-09-19
GT199900013A (es) 2001-07-20
BG64667B1 (bg) 2005-11-30
PL194350B1 (pl) 2007-05-31
PA8467801A1 (es) 2000-09-29
NO20003845D0 (no) 2000-07-27
CN1250221C (zh) 2006-04-12
EP1056419A4 (en) 2007-05-02
US5945117A (en) 1999-08-31
HUP0101268A2 (hu) 2001-09-28
HK1040901B (zh) 2006-11-24
NO319821B1 (no) 2005-09-19
AR017976A1 (es) 2001-10-24
KR20010040477A (ko) 2001-05-15
BG104715A (bg) 2001-02-28
PL342062A1 (en) 2001-05-21
JP2002501875A (ja) 2002-01-22

Similar Documents

Publication Publication Date Title
MA26600A1 (fr) Traitement du dysfonctionnement sexuel feminin.
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
EP1027057A4 (en) TREATMENT OF FEMALE SEXUAL DISORDERS
IL153492A0 (en) Treatment of male sexual dysfunction
PT1073658E (pt) Inibidores de ogmp pdes de pirazolopirimidinona para o tratamento da disfuncao sexual
ATE269866T1 (de) Intranasale zubereitungen zur behandlung sexueller störungen
GB0225908D0 (en) Treatment of female sexual dysfunction
NO20024442L (no) Behandling av seksuell dysfunksjon med apomorfin
MA26835A1 (fr) Traitement de l'emphyseme utilisant des agonistes retinoides selectifs des rar.
NO20032189L (no) Behandling av antidepresjonsmiddel-indusert seksuell dysfunksjon med apomorfin
NO20030978D0 (no) Behandling av diuresedysfunksjon
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
DE50009813D1 (de) Kombinationpräparat zur behandlung von sexueller dysfunktion
PL362980A1 (en) Treatment of sexual dysfunction
IL155775A0 (en) Treatment of male sexual dysfunction
GB0204919D0 (en) Treatment of female sexual dysfunction
FR2765214B1 (fr) Traitement de granulat par un latex anti-desenrobage
EA200200927A1 (ru) Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления
FR2806293B1 (fr) Implants scleraux pour le traitement du decollement de retine
GB0011926D0 (en) Treatment of sexual dysfunction
ZA200006378B (en) Compounds for the treatment of female sexual dysfunction.
FR2804331B1 (fr) Valve pour le traitement de l'hydrocephalie
SI1047428T1 (sl) Uporaba morfolinola za zdravljenje seksualne disfunkcije
GB0111037D0 (en) Treatment of sexual dysfunction
GB0109910D0 (en) Treatment of sexual dysfunction